Advanced manufacturing and industrialisation of the CGT sector – What’s next? We sat down with Katy, our Chief Scientific Officer, to discuss the recent ARM event, what the mood was like and the hot topics of discussion. Katy shared her thoughts on why robust...

The Promise and Challenges of Regulatory T Cell Therapy: A New Frontier in Immunotherapy In recent years, regulatory T cell (Treg) therapy has emerged as a ground breaking approach to cellular immunotherapy. Treg therapies hold immense potential to combat autoimmune...

The Best Cell and Gene Therapy Conferences of 2025As the new year begins, we asked our VP of Commercial, Lindsey Clarke, to share her top picks for the coming year and where you can expect to see the MFX team in the months ahead. While many of the events we attended...

Celebrating a Year of Innovation and Growth: MFX's Key Milestones in 2024 and a look ahead to how 2025 is shaping up! As we kick off 2025, we wanted to take a moment to reflect on the incredible journey we’ve had in 2024. It’s been a whirlwind of innovation,...

MFX's summer of studentsWhy investing time in the next generation helps give us new insights into our own technologies. A common theme that has come up within the team at MFX is that when we were making decisions earlier on in our careers, the information about what...

From cell culture to cell therapy - the biggest challenges of growing cells ex vivoDuring the development of the Cyto Engine platform we interviewed over 100 experts in cell culture and cell therapy manufacturing to understand what their biggest challenges were when...

Cutting the cost of CAR-Ts – Innovative strategies to make cell therapies more affordableT cells are the most extensively studied cell type in the development of cell therapies, constituting 58% of active UK ATMP clinical trials (1). CAR-T (Chimeric Antigen Receptor T...

Embracing Inclusivity: The CGT Circle X Pride - A Recap of The CGT Circle’s First-Ever WorkshopLast month The CGT Circle held it's first ever workshop event at Stevenage Bioscience Catalyst (SBC), supported by MFX and SBC and facilitated by The Honeycomb Works. A...

How to Innovate? The MFX wayCésaré Cejas, PhD gave a recent talk at the Bioengineering Symposium, a jointly organised event held by the Oxford University Bioengineering Society and Warwick BioSoc on the topic of "conceptualising innovations to confront current...

The Best Cell and Gene Therapy Conferences in 2024What are the best Cell and Gene Therapy conferences to attend in 2024?  We asked our VP of Commercial Lindsey Clarke what her top picks are for the coming year. It really depends on what your reasons are for wanting to...

Data and Digitization – The key to better biology and more effective therapiesData is the cornerstone of any scientific endeavor. But throughout history it’s been managed pretty poorly. Most data ever gathered on cells remain in hand-written lab notebooks, gathering...

Making cell therapies comPATible with large scale manufacturingProcess analytical technologies (PATs) cover a wide range of tools, playing an important role in initiatives such as quality by design (QbD), real-time release, and continuous manufacturing [1]. They are...